Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Monconduit

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Leukemia|June 25, 1998
Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseasesN V Smadja, C Fruchart, F Isnard, et al.
Blood|May 1, 1994
LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patientsC Bastard, C Deweindt, J P Kerckaert, et al.
Cancer|August 1, 1986
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTCM Hayat, U Jehn, R Willemze, et al.
American Journal of Hematology|October 1, 1994
Hematological toxicity of ticlopidineJ F Lesesve, M P Callat, B Lenormand, et al.
American Journal of Hematology|March 1, 1992
Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapyG Teixeira, B Lenormand, P Jean, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1994
[Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia]G Andreu, M Benbunan, M Boasson, et al.
Cancer Treatment Reports|October 1, 1987
Idarubicin in the treatment of relapsed or refractory acute myeloid leukemiaJ L Harousseau, P Hurteloup, J Reiffers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trialR Somers, P Carde, M Henry-Amar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative GroupP Carde, A Hagenbeek, M Hayat, et al.
Leukemia Research|December 29, 1999
Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphologyJ E Goasguen, M Zandecki, C Mathiot, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Leukemia|June 25, 1998
Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseasesN V Smadja, C Fruchart, F Isnard, et al.
Blood|May 1, 1994
LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patientsC Bastard, C Deweindt, J P Kerckaert, et al.
Cancer|August 1, 1986
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTCM Hayat, U Jehn, R Willemze, et al.
American Journal of Hematology|October 1, 1994
Hematological toxicity of ticlopidineJ F Lesesve, M P Callat, B Lenormand, et al.
American Journal of Hematology|March 1, 1992
Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapyG Teixeira, B Lenormand, P Jean, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1994
[Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia]G Andreu, M Benbunan, M Boasson, et al.
Cancer Treatment Reports|October 1, 1987
Idarubicin in the treatment of relapsed or refractory acute myeloid leukemiaJ L Harousseau, P Hurteloup, J Reiffers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trialR Somers, P Carde, M Henry-Amar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative GroupP Carde, A Hagenbeek, M Hayat, et al.
Leukemia Research|December 29, 1999
Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphologyJ E Goasguen, M Zandecki, C Mathiot, et al.
Pageof 8